Detailed information for compound 1673892

Basic information

Technical information
  • TDR Targets ID: 1673892
  • Name: 2-methyl-N-(phenylmethyl)imidazo[3,2-a]pyridi ne-3-carboxamide
  • MW: 265.31 | Formula: C16H15N3O
  • H donors: 1 H acceptors: 2 LogP: 3.27 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1c(C)nc2n1cccc2)NCc1ccccc1
  • InChi: 1S/C16H15N3O/c1-12-15(19-10-6-5-9-14(19)18-12)16(20)17-11-13-7-3-2-4-8-13/h2-10H,11H2,1H3,(H,17,20)
  • InChiKey: WPOCDGWQLAVORQ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-methyl-N-(phenylmethyl)-3-imidazo[3,2-a]pyridinecarboxamide
  • N-(benzyl)-2-methyl-imidazo[3,2-a]pyridine-3-carboxamide
  • Oprea1_255130
  • Oprea1_665686
  • ZINC00452374

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Mycobacterium tuberculosis Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium tuberculosis Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) Get druggable targets OG5_129569 All targets in OG5_129569
Mycobacterium leprae Probable pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) Get druggable targets OG5_129569 All targets in OG5_129569
Toxoplasma gondii pantoate-beta-alanine ligase Get druggable targets OG5_129569 All targets in OG5_129569
Neospora caninum pantoate--beta-alanine ligase, putative Get druggable targets OG5_129569 All targets in OG5_129569
Mycobacterium ulcerans pantoate--beta-alanine ligase Get druggable targets OG5_129569 All targets in OG5_129569
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi hypothetical protein, conserved 0.004 0.0031 0.5
Onchocerca volvulus 0.004 0.0031 0.5
Trichomonas vaginalis esterase, putative 0.004 0.0031 0.5
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.004 0.0031 1
Loa Loa (eye worm) beta-lactamase 0.004 0.0031 0.0226
Loa Loa (eye worm) MH2 domain-containing protein 0.0133 0.1386 1
Loa Loa (eye worm) hypothetical protein 0.004 0.0031 0.0226
Trichomonas vaginalis penicillin-binding protein, putative 0.004 0.0031 0.5
Trichomonas vaginalis penicillin-binding protein, putative 0.004 0.0031 0.5
Brugia malayi beta-lactamase family protein 0.004 0.0031 0.0226
Brugia malayi beta-lactamase family protein 0.004 0.0031 0.0226
Loa Loa (eye worm) hypothetical protein 0.004 0.0031 0.0226
Echinococcus granulosus beta LACTamase domain containing family member 0.004 0.0031 0.5
Loa Loa (eye worm) hypothetical protein 0.004 0.0031 0.0226
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.004 0.0031 0.0226
Trichomonas vaginalis D-aminoacylase, putative 0.004 0.0031 0.5
Trypanosoma brucei hypothetical protein, conserved 0.004 0.0031 0.5
Onchocerca volvulus 0.004 0.0031 0.5
Toxoplasma gondii pantoate-beta-alanine ligase 0.0725 1 1
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0056 0.0256 0.1849
Trichomonas vaginalis D-aminoacylase, putative 0.004 0.0031 0.5
Mycobacterium tuberculosis Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) 0.0725 1 1
Trichomonas vaginalis D-aminoacylase, putative 0.004 0.0031 0.5
Brugia malayi MH2 domain containing protein 0.0133 0.1386 1
Echinococcus multilocularis beta LACTamase domain containing family member 0.004 0.0031 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.004 0.0031 0.5
Loa Loa (eye worm) hypothetical protein 0.0056 0.0256 0.1849
Brugia malayi beta-lactamase 0.004 0.0031 0.0226
Loa Loa (eye worm) hypothetical protein 0.004 0.0031 0.0226
Leishmania major hypothetical protein, conserved 0.004 0.0031 0.5
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0257 0.3183 0.3162
Loa Loa (eye worm) transcription factor SMAD2 0.0133 0.1386 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.0056 0.0256 0.1849
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.004 0.0031 1
Mycobacterium ulcerans pantoate--beta-alanine ligase 0.0725 1 1
Loa Loa (eye worm) hypothetical protein 0.004 0.0031 0.0226
Loa Loa (eye worm) hypothetical protein 0.004 0.0031 0.0226
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0056 0.0256 0.1849
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.004 0.0031 0.0226
Plasmodium vivax hypothetical protein, conserved 0.004 0.0031 0.5
Onchocerca volvulus 0.004 0.0031 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 2.74 uM Inhibition of Mycobacterium tuberculosis pantothenate synthetase expressed in Escherichia coli BL21 (DE3) by spectrophotometry ChEMBL. 24953948
Inhibition (ADMET) = 24.5 % Cytotoxicity against mouse RAW264.7 cells assessed as inhibition of cell viability at 50 uM after 72 hrs by MTT assay ChEMBL. 24953948
MIC (functional) = 23.5 uM Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 28 days by agar dilution method ChEMBL. 24953948
MIC50 (functional) = 0.2 uM Antimycobacterial activity against Mycobacterium tuberculosis assessed as inhibition of bacterial growth measured in glycerol-containing medium ChEMBL. 25577708
MIC50 (functional) = 1.86 uM Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method ChEMBL. 27184765
MIC90 (functional) = 2 uM GSK_TB: Intracellular minimum inhibitory concentration (MIC) H37Rv assay ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.